LENZ Therapeutics (LENZ) Operating Leases (2021 - 2026)
LENZ Therapeutics (LENZ) reported Operating Leases of $237000.0 for Q1 2026, down 64.78% year-over-year from $673000.0 in Q1 2025, and down 32.29% quarter-over-quarter from $350000.0 in Q4 2025.
LENZ Therapeutics (LENZ) Operating Leases (2021 - 2026) Analysis & Trends
LENZ Therapeutics (LENZ) has 6 years of Operating Leases data on file, last reported at $237000.0 in Q1 2026.
- Operating Leases for Q1 2026 came in at $237000.0, down 64.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $237000.0 (down 64.78% YoY), and the FY2025 annual result was $350000.0, down 57.0% from the prior year.
- Operating Leases retreated to $237000.0 in Q1 2026 per LENZ's latest filing, from $350000.0 in the prior quarter.
- Over five years, Operating Leases peaked at $50.6 million in Q2 2023 and troughed at $192000.0 in Q4 2023.
- A 5-year average of $7.1 million and a median of $1.4 million in 2023 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2023 and 2024: Operating Leases soared 1888.0% in 2023, then tumbled 97.12% in 2024.
- A 5-year view of Operating Leases shows it stood at $1.7 million in 2022, then sank by 89.02% to $192000.0 in 2023, then surged by 323.96% to $814000.0 in 2024, then tumbled by 57.0% to $350000.0 in 2025, then tumbled by 32.29% to $237000.0 in 2026.
- Business Quant data shows LENZ's Operating Leases at $237000.0 in Q1 2026, $350000.0 in Q4 2025, and $461000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | LENZ Therapeutics | 192.19 Mn | 192.19 Mn | 825,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 237,000.00 |
| Dec 31, 2025 | 350,000.00 |
| Sep 30, 2025 | 461,000.00 |
| Jun 30, 2025 | 569,000.00 |
| Mar 31, 2025 | 673,000.00 |
| Dec 31, 2024 | 814,000.00 |
| Sep 30, 2024 | 1.43 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Mar 31, 2024 | 296,000.00 |
| Dec 31, 2023 | 192,000.00 |
| Sep 30, 2023 | 49.70 Mn |
| Jun 30, 2023 | 50.60 Mn |
| Mar 31, 2023 | 1.40 Mn |
| Dec 31, 2022 | 1.75 Mn |
| Sep 30, 2022 | 2.50 Mn |
| Jun 30, 2022 | 3.30 Mn |
| Mar 31, 2022 | 4.54 Mn |
| Dec 31, 2021 | 5.79 Mn |
| Sep 30, 2021 | 4.68 Mn |